Palvella Therapeutics (PVLA) Amortization of Deferred Charges (2019 - 2021)
Palvella Therapeutics' (PVLA) quarterly Amortization of Deferred Charges came in at -$23000.0 in Q2 2021, up 46.51% year-on-year from -$15698.4 in Q2 2020, and up 8.0% on a QoQ basis from -$25000.0 in Q1 2021.
Palvella Therapeutics (PVLA) Amortization of Deferred Charges (2019 - 2021) Analysis & Trends
Palvella Therapeutics (PVLA) has 3 years of Amortization of Deferred Charges data on file, last reported at -$23000.0 in Q2 2021.
- On a quarterly basis, Amortization of Deferred Charges rose 46.51% year-over-year to -$23000.0 in Q2 2021; TTM through Jun 2021 was -$388000.0, a 211.17% decrease from a year earlier, with the FY2021 full-year figure at -$91000.0, up 50.54% from the prior year.
- Amortization of Deferred Charges for Q2 2021 stood at -$23000.0, up from -$25000.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for PVLA reached as high as $199000.0 in Q1 2020 and fell as low as -$259000.0 in Q3 2020.
- Historically, Amortization of Deferred Charges has averaged -$4875.0 across 3 years, with a median of -$24000.0 in 2021.
- Across the five-year window, Amortization of Deferred Charges sank 359.0% in 2020 and jumped 46.51% in 2021, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $93000.0 in 2019, then plunged by 187.1% to -$81000.0 in 2020, then surged by 71.6% to -$23000.0 in 2021.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were -$23000.0 in Q2 2021, -$25000.0 in Q1 2021, and -$81000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Palvella Therapeutics | 1.88 Bn | 1.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -23,000.00 |
| Jun 30, 2021 | -23,000.00 |
| Mar 31, 2021 | -25,000.00 |
| Mar 31, 2021 | -25,000.00 |
| Dec 31, 2020 | -81,000.00 |
| Dec 31, 2020 | -81,000.00 |
| Sep 30, 2020 | -259,000.00 |
| Sep 30, 2020 | -259,000.00 |
| Jun 30, 2020 | -43,000.00 |
| Jun 30, 2020 | -43,000.00 |
| Mar 31, 2020 | 199,000.00 |
| Mar 31, 2020 | 199,000.00 |
| Dec 31, 2019 | 93,000.00 |
| Dec 31, 2019 | 93,000.00 |
| Sep 30, 2019 | 100,000.00 |
| Sep 30, 2019 | 100,000.00 |